Long-term dual antiplatelet therapy after percutaneous coronary intervention

Long-term dual antiplatelet therapy after percutaneous coronary intervention

“…We agree with Andrea Messori et al 2 that our study may not be adequately powered to evaluate small differences in outcomes between patient groups, and that large-scale randomised clinical studies are the best way to define the optimal duration of dual antiplatelet therapy.…”